News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
107last 24h
3126last 7d
511● bullish (7d)
311● bearish (7d)
227publishers
24/7 Wall St.1d agoneutral
Gilead Pays a $3.28 Annual Dividend Despite Negative Earnings. Is It Safe?MT Newswires2d agoneutral
Gilead Sciences Says Twice-Yearly Lenacapavir Shows Higher PrEP Persistence in Phase 2 TrialClinical Trials Arena2d agoneutral
Gilead seeks wider use for Livdelzi on Phase III liver disease successSimply Wall St.3d agobullish
Did Earnings Beat Just Shift Gilead Sciences' (GILD) Investment Narrative?GuruFocus.com3d agoneutral
Vir Biotechnology Inc (VIR) (Q3 2026) Earnings Call Highlights: Hepatitis Delta Data on Deck ...Business Wire4d agoneutral
Vir Biotechnology Provides Corporate Update and Reports Third Quarter 2026 Financial ResultsBusiness Wire4d agoneutral
Gilead and Kite Advance Leadership With New Data Across Pipeline and Portfolio at ASH 2026Simply Wall St.5d agoneutral
BioNTech (BNTX) Enters First Global Phase 3 Trial For New Breast Cancer ComboGlobeNewswire5d agoneutral
BioNTech Announces Third Quarter 2026 Financial Results and Corporate UpdateSimply Wall St.6d agoneutral
Gilead (GILD) Stock Fair Value Edges Higher After Analyst Target IncreasesBusiness Wire6d agoneutral
Gilead to Present Late-Breaking Clinical Data and Real-World Evidence at HIV Glasgow